Trexquant Investment LP Pmv Pharmaceuticals, Inc. Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$6.01 - $8.93 $409,894 - $609,043	68,202 New	68,202 $418,000
Q1 2023 May 15, 2023	BUY	$4.77 - $9.16 $85,373 - $163,945	17,898 Added 68.19%	44,144 $210,000
Q4 2022 Feb 13, 2023	SELL	$8.17 - $12.95 $195,745 - $310,269	-23,959 Reduced 47.72%	26,246 $228,000
Q3 2022 Nov 14, 2022	BUY	$11.4 - $17.18 $572,337 - $862,521	50,205 New	50,205 $597,000
Q1 2022 May 13, 2022	SELL	$14.86 - $23.55 $197,103 - $312,367	-13,264 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$19.99 - $30.24 $265,147 - $401,103	13,264 New	13,264 $306,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $72.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.